Engineering New Variants of Common Antibiotics Could Stave Off Drug Resistance (IMAGE)

American Association for the Advancement of Science (AAAS)

Engineering New Variants of Common Antibiotics Could Stave Off Drug Resistance

Caption

Designer erythromycin analogues show activity against resistant bacteria. This material relates to a paper that appeared in the May 29, 2015, issue of Science, published by AAAS. The paper, by G. Zhang at University at Buffalo, The State University of New York in Buffalo, NY, and colleagues was titled, "Tailoring pathway modularity in the biosynthesis of erythromycin analogs heterologously engineered in E. coli."

Credit

[Credit: Zhang, <i>et al.</i> Sci. Adv. 2015;1:e1500077]

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.